Putting 2-1-1 into Practice: PrEP Users' Knowledge of Effectively Starting and Stopping Oral PrEP Use

被引:6
|
作者
Rotsaert, Anke [1 ]
Reyniers, Thijs [1 ]
Vanhamel, Jef [1 ]
Van Landeghem, Ella [1 ]
Vanbaelen, Thibaut [2 ]
Van Mieghem, Heleen [1 ]
Nostlinger, Christiana [1 ]
Laga, Marie [1 ]
Vuylsteke, Bea [1 ]
机构
[1] Inst Trop Med, Dept Publ Hlth, Nationalestr 155, B-2000 Antwerp, Belgium
[2] Inst Trop Med, Dept Clin Sci, Nationalestr 155, B-2000 Antwerp, Belgium
关键词
PrEP; Adherence; 2-1-1; On-demand; HIV prevention; MSM; HIV PREEXPOSURE PROPHYLAXIS; SAFETY;
D O I
10.1007/s10461-022-03911-2
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Starting and stopping oral HIV pre-exposure prophylaxis (PrEP) in a way that compromises its effectiveness should be avoided. Between September 2020 and June 2021, we assessed self-perceived and actual knowledge of effectively starting and stopping oral PrEP through an online survey among 206 PrEP users assigned male at birth in Belgium. We examined associations between incorrect start-and-stop knowledge and socio-demographics, sexual behaviour and PrEP use, using bi- and multi-variable logistic regression. The majority of men (84.9%) perceived their start-and-stop knowledge as 'very good', but only 62.1% of all men correctly indicated how to effectively start and stop with PrEP. Using PrEP daily [adjusted OR 2.12, 95% CI (1.06-4.28), p = 0.034] was significantly associated with incorrect start-and-stop knowledge. To enable PrEP users to effectively use PrEP, they need to be better informed about how to start and stop use, irrespective of the dosing regimen.
引用
收藏
页码:1793 / 1799
页数:7
相关论文
共 3 条
  • [1] Putting 2-1-1 into Practice: PrEP Users’ Knowledge of Effectively Starting and Stopping Oral PrEP Use
    Anke Rotsaert
    Thijs Reyniers
    Jef Vanhamel
    Ella Van Landeghem
    Thibaut Vanbaelen
    Heleen Van Mieghem
    Christiana Nöstlinger
    Marie Laga
    Bea Vuylsteke
    AIDS and Behavior, 2023, 27 : 1793 - 1799
  • [2] Incorrect Knowledge of Event-Driven PrEP "2-1-1" Dosing Regimen Among PrEP-Experienced Gay and Bisexual Men in Australia
    Chan, Curtis
    Vaccher, Stefanie
    Fraser, Doug
    Grulich, Andrew E.
    Holt, Martin
    Zablotska-Manos, Iryna
    Prestage, Garrett P.
    Bavinton, Benjamin R.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2022, 90 (02) : 132 - 139
  • [3] Routine Use of Oral PrEP in a Phase 2 Rectal Microbicide Study of Tenofovir Reduced-Glycerin 1% Gel (MTN-017)
    Liu, Albert Y.
    Norwood, Aliza
    Gundacker, Holly
    Carballo-Dieguez, Alex
    Johnson, Sherri
    Patterson, Karen
    Bekker, Linda-Gail
    Chariyalertsak, Suwat
    Chitwarakorn, Anupong
    Gonzales, Pedro
    Holtz, Timothy H.
    Mayer, Kenneth H.
    Zorrilla, Carmen
    Buchbinder, Susan
    Piper, Jeanna M.
    Lama, Javier R.
    Cranston, Ross D.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2019, 81 (05) : 516 - 520